ES2677219T3 - Derivados multivalentes de ácido siálico - Google Patents

Derivados multivalentes de ácido siálico Download PDF

Info

Publication number
ES2677219T3
ES2677219T3 ES14758353.8T ES14758353T ES2677219T3 ES 2677219 T3 ES2677219 T3 ES 2677219T3 ES 14758353 T ES14758353 T ES 14758353T ES 2677219 T3 ES2677219 T3 ES 2677219T3
Authority
ES
Spain
Prior art keywords
sialic acid
formula
groups
advh
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14758353.8T
Other languages
English (en)
Spanish (es)
Inventor
Niklas Arnberg
Rémi CARABALLO
Mikael Elofsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adenovir Pharma AB
Original Assignee
Adenovir Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenovir Pharma AB filed Critical Adenovir Pharma AB
Application granted granted Critical
Publication of ES2677219T3 publication Critical patent/ES2677219T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES14758353.8T 2013-08-28 2014-08-28 Derivados multivalentes de ácido siálico Active ES2677219T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1350991 2013-08-28
SE1350991 2013-08-28
PCT/EP2014/068252 WO2015028548A1 (en) 2013-08-28 2014-08-28 Multivalent sialic acid derivates

Publications (1)

Publication Number Publication Date
ES2677219T3 true ES2677219T3 (es) 2018-07-31

Family

ID=51454687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14758353.8T Active ES2677219T3 (es) 2013-08-28 2014-08-28 Derivados multivalentes de ácido siálico

Country Status (13)

Country Link
US (1) US10011628B2 (enExample)
EP (1) EP3039029B1 (enExample)
JP (1) JP6360895B2 (enExample)
KR (1) KR20160073372A (enExample)
CN (1) CN105722849B (enExample)
AU (1) AU2014314212B2 (enExample)
CA (1) CA2921634A1 (enExample)
ES (1) ES2677219T3 (enExample)
IL (1) IL244246B (enExample)
MX (1) MX2016002578A (enExample)
PL (1) PL3039029T3 (enExample)
TR (1) TR201809630T4 (enExample)
WO (1) WO2015028548A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904289D0 (sv) 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20070020620A1 (en) * 2005-07-14 2007-01-25 Finn M G Compositions and methods for coupling a plurality of compounds to a scaffold
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
BR112012000381A2 (pt) 2009-07-07 2016-03-29 Adenovir Pharma Ab novos compostos antivirais úteis para o tratamento ou prevenção de queratoconjuntivite epidêmica
KR101217685B1 (ko) 2010-05-28 2013-01-02 서강대학교산학협력단 서로 다른 실릴기로 보호된 알킨 그룹을 갖는 삼중연결고리 화합물, 이의 제조방법 및 응용
WO2011158068A1 (en) 2010-06-18 2011-12-22 Centre National De La Recherche Scientifique (Cnrs) Non covalent molecular structure, device comprising the same and its use for detection of lectin

Also Published As

Publication number Publication date
IL244246B (en) 2019-02-28
CA2921634A1 (en) 2015-03-05
KR20160073372A (ko) 2016-06-24
EP3039029B1 (en) 2018-04-11
CN105722849B (zh) 2019-01-29
IL244246A0 (en) 2016-04-21
CN105722849A (zh) 2016-06-29
WO2015028548A1 (en) 2015-03-05
US10011628B2 (en) 2018-07-03
EP3039029A1 (en) 2016-07-06
MX2016002578A (es) 2016-09-08
US20160207955A1 (en) 2016-07-21
AU2014314212A1 (en) 2016-03-10
AU2014314212B2 (en) 2018-03-01
PL3039029T3 (pl) 2018-10-31
JP6360895B2 (ja) 2018-07-18
JP2016529269A (ja) 2016-09-23
TR201809630T4 (tr) 2018-07-23

Similar Documents

Publication Publication Date Title
TW202142231A (zh) 用於降解胞外蛋白質之結合ａｓｇｐｒ之化合物
ES2921500T3 (es) 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas
CN108884121B (zh) 新组合物和治疗方法
CN110869378A (zh) 预防和治疗疾病的化合物及其用途
ES2776255T3 (es) Novedoso inhibidor de galactósido de galectinas
CN111971280A (zh) 杂芳基化合物、其药物组合物和其治疗用途
WO2022140246A1 (en) Methods and compounds for targeted autophagy
CN101679472B (zh) 用于预防或治疗病毒感染的化合物及其应用方法
WO2008029278A2 (en) Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
ES2788475T3 (es) Agentes antivirales y usos de estos
WO2020010158A1 (en) Methods and compounds for the treatment of genetic disease
CA2535802A1 (en) Novel sulfenamides
ES2524363T3 (es) Compuestos glicomiméticos como agentes antiinfecciosos frente a lectinas patógenas
US10011628B2 (en) Multivalent sialic acid derivatives
RU2565593C2 (ru) Новые противовирусные соединения, подходящие для лечения или предотвращения эпидемического кератоконъюнктивата
WO2013152848A1 (en) Glycomimetics as pseudomonas aeruginosa lectin inhibitors
AU2022404776A1 (en) Lectin-targeting conjugates
WO2025168118A1 (zh) 具有nlrp3抑制活性的磺酰脲类衍生物及其应用
AU2004266177A1 (en) Novel sulfenamides